MED
Medifast·NYSE
--
--(--)
--
--(--)
5.98 / 10
Netural
Sentiment is neutral (5.98) and fund flow is good at 7.8, with overall inflow ratios above 0.52 except small investors turning negative. Analyst coverage is limited to one neutral rating, indicating mixed expectations despite strong capital inflows.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Jim SaleraNeutral
Date2026-02-19
InstitutionStephens & Co.
Times predicted1
Historical Win Rate100.0%
What is the market sentiment for MED?
- MED holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.98/10 (Netural).
